1. Biomarkers

    Comments Leave a Comment

    1-14 of 14
    1. Mentioned In 14 Articles

    2. Coexpression network analysis identifies transcriptional modules associated with genomic alterations in neuroblastoma.

      ...genomic alterations including MYCN amplification, 1p deletion and 11q deletion are important risk factors and biomarkers in neuroblastoma. Here, we performed a co-expression-based gene network analysis to study the intri...
      Read Full Article
      Mentions: MYCN Biomarkers
    3. Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After (131)I- Metaiodobenzylguanidine Therapy in Patients With Neuroblastoma.

      ...ree of modulation in serum amylase was significantly lower after the second course (P=.012). Peripheral blood biomarkers relevant to radiation exposure are significantly modulated during the acute period after 131I-MIBG....
      Read Full Article
    4. Simple test predicts childhood cancer relapse

      Simple test predicts childhood cancer relapse
      Researchers at Brunel University London and University College London have pinpointed a protein marker, which when absent, shows neuroblastoma is almost certain to recur. It means children with low-risk neuroblastoma, who dont have the biomarker called PML, can be reclassified as at high risk of relapse and have chemotherapy earlier. A cheap simple test could accurately predict the recurrence of a childhood cancer.
      Read Full Article
    5. 1-14 of 14
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Quotes about Biomarkers

    1. We already knew that 11q deletions are biomarkers that predict poor outcomes in neuroblastoma.
      In Researchers identify gene variants linked to a high-risk children's cancer
    2. We already knew that 11q deletions are biomarkers that predict poor outcomes in neuroblastoma.
      In Researchers Identify Gene Variants Linked to a High-Risk Children's Cancer
    3. Our paper gives us some clues as to predictive biomarkers of who might respond best to this type of treatment.
      In Combining immunotherapies effective against mouse model of cancer